TickerFactsScreenerDevelopers

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2007: $61.0K2008: $2.3K2009: -$13.5K2010: $638.1K2011: -$12.78M2012: -$11.32M2013: $17.60M2014: $44.84M2015: $104.02M2016: $166.92M2017: $145.48M2018: $466.19M2019: $298.97M2020: $656.50M2021: $621.66M2022: $499.64M2023: $584.61M2024: $710.40M2025: $698.58M$698.58M
2007Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$698.58M-1.7%
2024$710.40M+21.5%
2023$584.61M+17.0%
2022$499.64M-19.6%
2021$621.66M-5.3%
2020$656.50M+119.6%
2019$298.97M-35.9%
2018$466.19M+220.4%
2017$145.48M-12.8%
2016$166.92M+60.5%
2015$104.02M+132.0%
2014$44.84M+154.8%
2013$17.60M+255.5%
2012-$11.32M+11.4%
2011-$12.78M-2103.0%
2010$638.1K+4830.8%
2009-$13.5K-690.5%
2008$2.3K-96.3%
2007$61.0K—